2020 Nelson's Pediatric Antimicrobial Therapy
Zusammenfassung
The feel-good place to buy books

2020 Nelson's Pediatric Antimicrobial Therapy by John S Bradley
The 26th edition provides practical, evidence-based recommendations from the experts in antimicrobial therapy for treatment of infectious diseases in children. For each disease, the authors provide a commentary to help health care providers select the best of all antimicrobial choices. Drug descriptions cover pediatric-appropriate antimicrobial agents available today and include complete information about dosing regimens. New in the 26th edition:- First pediatric approval of beta-lactam/beta-lactamase inhibitor for CRE (carbapenem-resistant enteric bacilli), ceftazidime-avibactam
- Replacement antibiotics for cefotaxime (lack of availability in the US), including ceftriaxone and cefepime (for neonates)
- Situations in which ceftaroline is preferred over vancomycin by the Editors for MRSA infections
- Updates on management of influenza, including baloxavir (now approved for children >12 years)
- New approaches to treatment of mucomycosis
- New recommendations for malaria
- More than 150 new references>
2020 Nelson's Pediatric Antimicrobial Therapy has been selected as one of Doody’s Core Titles®
| SKU | Nicht verfügbar |
| ISBN 13 | 9781610023528 |
| ISBN 10 | 1610023528 |
| Titel | 2020 Nelson's Pediatric Antimicrobial Therapy |
| Autor | John S Bradley |
| Buchzustand | Nicht verfügbar |
| Bindungsart | Paperback |
| Verlag | American Academy of Pediatrics |
| Erscheinungsjahr | 2020-01-30 |
| Seitenanzahl | 320 |
| Hinweis auf dem Einband | Die Abbildung des Buches dient nur Illustrationszwecken, die tatsächliche Bindung, das Cover und die Auflage können sich davon unterscheiden. |
| Hinweis | Nicht verfügbar |